In previous Korean studies, the NGS-based platforms (Oncomine Lung cfDNA and Pan-Cancer Cell-Free Assays) were more sensitive than the cobas® EGFR Mutation Test v2 for the detection of mutations with a VAF of 0.1 [11,12]. Here, EGFR is linked to cancer.